Down's syndrome screening using free βhCG: Instability can significantly increase the Down's risk estimate

Annals of Clinical Biochemistry

Volumn 33, Issue 6, 1996, Pages 525-529

  Beaman, Janine M ^a   Akhtar, Naheed ^a   Goldie, David J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

AFP; Dual AFP hCG assay; Storage of blood samples

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; FETOPROTEIN;

ARTICLE; DOWN SYNDROME; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

EID: 0029959728     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300606     Document Type: Article

References (14)

1. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-7
2. Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. Maternal Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotrophin. Am J Obstet Gynecol 1990; 163: 1248-53
3. Spencer K. Evaluation of an assay of the free β-subunit of choriogonadotrophin and its potential value in screening for Down's syndrome. Clin Chem 1991; 37: 809-14
4. Spencer K, Coombes EJ, Mallard AS, Milford Ward A. Free beta human choriogonadotrophin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992; 29: 506-13
5. Stevenson JM, Leslie H, Sheridan B. Serum free β-human Chorionic gonadotrophin concentrations increase in unseparated blood specimens. Ann Clin Biochem 1993; 30: 99-100
6. Spencer K, Macri JN, Carpenter P, Anderson R, Krantz DA. Stability of intact chorionic gonadotrophin (hCG) in serum, liquid whole-blood and dried whole blood filter-paper spots: Impact on screening for Down syndrome by measurement of free βhCG subunit. Clin Chem 1993; 6: 1064-8
7. Sanken U, Bahner D. The effect of thermal instability of intact human chorionic gonadotrophin (IhCG) on the application of its free β-subunit (free βhCG) as a serum marker in Down syndrome screening. Prenat Diagn 1995; 15: 731-8
8. Petterson K, Alfthan H, Stenman U, Turpeinen U, Suonpää M, Söderholm J, et al. Simultaneous assay of α-fetoprotein and free β-subunit of human chorionic gonadotrophin by dual label time resolved immunofluorimetric assay, Clin Chem 1993; 10: 2084-9
9. Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated with pregnancy. Ann Clin Biochem 1990; 27: 452-8
10. Cuckle HS, Jones RG. Maternal serum free β-human chorionic gonadotrophin level: the effect of sample transportation. Ann Clin Biochem 1994; 31: 97-8
11. Macri JN, Spencer K, Garver K, Buchanan PD, Say B, Carpenter NJ, et al. Maternal serum free beta hCG screening: Results of studies including 480 cases of Down syndrome. Prenatal Diagn 1994; 14: 97-103
12. Spencer K, Carpenter P. Prospective study of prenatal screening for Down's syndrome with free β chorionic gonadotrophin. BMJ 1993; 307: 764-9
13. Spencer K, Carpenter P. Down's syndrome screening using free beta-hCG: two years prospective screening experience. Proc UK NEQAS Meet 1994; 1: 41-3
14. Goldie DJ, Astley JP, Beaman JM, Bickley DA, Gunneberg A, Jones SR. Screening for Down's syndrome: the first two years experience in Bristol. J Med Screen 1995; 2: 207-10